BamSEC and AlphaSense Join Forces
Learn More

Avenue Therapeutics Inc. – Indentures

OTC: ATXI    
Share price (10/7/26): $0.45    
Market cap (10/7/26): $1.479 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from 10-K ~10 pages Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Capital Stock
12/34/56
EX-4.3
from 10-K ~10 pages Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Capital Stock
12/34/56
EX-4.10
from S-3 43 pages Avenue Therapeutics, Inc. and Trustee Indenture Dated as of Debt Securities
12/34/56
EX-4.3
from 8-K 3 pages Placement Agent Common Stock Purchase Warrant Avenue Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 3 pages Series D Common Stock Purchase Warrant Avenue Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 3 pages Series C Common Stock Purchase Warrant Avenue Therapeutics, Inc
12/34/56
EX-4.3
from 10-K ~10 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Capital Stock
12/34/56
EX-4.2
from 8-K 17 pages Series B Common Stock Purchase Warrant Avenue Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 17 pages Series a Common Stock Purchase Warrant Avenue Therapeutics, Inc
12/34/56
EX-4.4
from 8-K 15 pages Warrant Agent Agreement
12/34/56
EX-4.3
from 8-K 16 pages Prefunded Common Stock Purchase Warrant Avenue Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 17 pages Series B Common Stock Purchase Warrant Avenue Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 17 pages Series a Common Stock Purchase Warrant Avenue Therapeutics, Inc
12/34/56
EX-4.10
from S-1/A 15 pages Warrant Agent Agreement
12/34/56
EX-4.8
from S-1/A 17 pages [Series a/Series B] Common Stock Purchase Warrant Avenue Therapeutics, Inc
12/34/56
EX-4.10
from S-1/A 14 pages Warrant Agent Agreement
12/34/56
EX-4.9
from S-1/A 16 pages Prefunded Common Stock Purchase Warrant Avenue Therapeutics, Inc
12/34/56
EX-4.3
from 10-K 7 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Capital Stock
12/34/56
EX-4.3
from 8-K 14 pages Warrant Agent Agreement
12/34/56
EX-4.2
from 8-K 16 pages Pre-Funded Common Stock Purchase Warrant Avenue Therapeutics, Inc
12/34/56